PSAMP
OCEA

P. Schoenfeld Asset Management (PSAM)’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-80,263
Closed -$835K – 159
2022
Q4 		$835K Hold
80,263
– – 0.08% 123
2022
Q3 		$818K Hold
80,263
– – 0.05% 183
2022
Q2 		$811K Buy
+80,263
New +$811K 0.05% 210

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s OCEA Position: Q1 2023 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 80,263 shares — an estimated $835K sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in OCEA in Q2 2022 and held it in 3 quarters. The position peaked at $835K in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 80,263 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $835K.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Ocean Biomedical, Inc. Common Stock position peaked at $835K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q1 2023, filed 15 May 2023.